首页 | 官方网站   微博 | 高级检索  
     

酮替芬对链脲佐菌素诱导的糖尿病模型大鼠胰岛功能的影响
引用本文:陈咨苗,陈肖俊,王美荣,潘亮亮,胡万里,倪连松.酮替芬对链脲佐菌素诱导的糖尿病模型大鼠胰岛功能的影响[J].中国临床药理学与治疗学,2013,18(6):627-632.
作者姓名:陈咨苗  陈肖俊  王美荣  潘亮亮  胡万里  倪连松
作者单位:1. 温州医学院附属第一医院内分泌科,温州325000,浙江
2. 温州医学院电镜中心,温州325000,浙江
基金项目:温州市科技局基金资助(Y20100063)
摘    要:目的:探讨酮替芬对链脲佐菌素诱导的糖尿病模型大鼠胰岛功能的影响及其作用机制.方法:以高糖高脂饲料对SD大鼠饮食诱导6周,随后一次性i.p.给予链脲佐菌素(STZ)制备糖尿病大鼠模型.模型建立后,实验组给予酮替芬0.09 mg·kg-1·d-1,分别在第0、4、8周宰杀实验大鼠,检测空腹血糖(FBG)、空腹胰岛素(FINS),计算胰岛素敏感指数(ISI)、胰岛素抵抗指数(HOMA-IR),检测炎症因子IL-6、TNF-α,并留取胰腺组织,制片染色进行光镜、电镜观察.分离胰岛细胞线粒体,检测细胞色素C氧化酶(Cytochrome C oxidase,CCO)、琥珀酸脱氢酶(Succinate dehydrogenase,SDH)活性.结果:酮替芬降低糖尿病大鼠的血糖水平(P<0.05),增加ISI和降低HOMA-IR(P<0.01),降低IL-6和TNF-α水平,增加胰腺组织中CCO和SDH活性(P<0.01),还可以改善胰岛细胞形态结构.结论:酮替芬能改善糖尿病大鼠的胰岛功能,其作用机制可能是通过抑制NF-кB激活实现抗炎及改善β细胞线粒体的能量代谢.

关 键 词:酮替芬  糖尿病  胰岛功能  血糖

Effect of Ketotifen on pancreatic function of streptozotocin-induced type 2 diabetic rats
CHEN Zi-miao,CHEN Xiao-jun,WANG Mei-rong,PAN Liang-liang,HU Wan-li,NI Lian-song.Effect of Ketotifen on pancreatic function of streptozotocin-induced type 2 diabetic rats[J].Chinese Journal of Clinical Pharmacology and Therapeutics,2013,18(6):627-632.
Authors:CHEN Zi-miao  CHEN Xiao-jun  WANG Mei-rong  PAN Liang-liang  HU Wan-li  NI Lian-song
Affiliation:1Department of Endocrinology, the First Affiliated Hospital of Wenzhou Medical College; e Electron Microscopy Center of Wenzhou Medical College, Wenzhou 325000, Zhejiang, China)
Abstract:Abstract: OBJECTIVE To investigate the effect and mechanism of Ketotifen on pancreati-c function of streptozotocin-induced type 2 diabetic rats. METHODS Male SD rats werefed with high-carbon hydrate-fat diet 6 weeks and ip given STZ to induce a type 2 diab-etes model. Rats of Ketotifen group were fed with Ketotifen 0.09mg/kg?d,and killed in batches in different time(o,4th,8th week)to test the fasting blood glucose(FBG)、fasting pl-asma insulin(FINS), and calculated the insulin sensitivity index(ISI) and homeostasis mo-del assessment insulin resistance index(HOMA-IR),to test the level of Interleukin-6(IL-6)、t-umor nectosis factor-alpha(TNF-α),and the pancreatic tissue were excised and observed b-y light microscope(LM) and transmission electron microscope, islet cell mitochondria wer-e separated to test the activity of cytochrome C oxidase(CCO) and succinate dehydrogenase(SDH). RESULTS Ketotifen suppressed serum glucose in diabetic rats(P〈0.05), increase-d ISI and reduced HOMA-IR(P〈0.01), Ketotifen reduced serum IL-6,TNF-α, increased the activity of CCO and SDH.furthermore, Ketotifen can improve the morphological struc-ture of islet cell. CONCLUSION Ketotifen can improve the pancreatic function of strep-tozotocin-induced type 2 diabetic rats possibly by inhibition of activation of NF-κB to anti-inflammatory and improve the energy metabolism of βcell mitochondria.
Keywords:Ketotifen  Diabetes mellitus  Pancreatic function  Blood glucose
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号